PRMT | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

304 results for “PRMT”

Trials

View all 160 →

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

450 participants · First posted Apr 6, 2025

Enrolling By Invitation

The Correlation Between Serum PRMT5 Level and Cardiac Ultrasound Indicators in Patients With Heart Failure

50 participants · First posted Jul 3, 2025

A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer

40 participants · First posted Dec 21, 2020

Drugs

View all 85 →

PRMT5

CT-300

ABK-PRMT5-1

Organizations

Universidad Arturo Prat

Chile

PRM PHARMA, LLC

United States

News

View all 57 →

UNF Researchers Advance Cancer-Fighting Compound to Animal Trials After Breakthrough Discovery

Decoding the PTM Code of cGAS-STING in Gastric Cancer: From Innate DNA Sensing to Precision Combination Therapy

Amgen and Ideaya Terminate Cancer Combination Trial for PRMT5 and MAT2A Inhibitors

Page 1 of 31